With the annual J.P. Morgan Healthcare Conference, where several biotech stalwarts like Celgene Corp (CELG – Analyst Report) and Vertex Pharmaceuticals Inc. (VRTX – Analyst Report) provided updates, investor focus will now shift to the next big thing in the biotech sector, the fourth quarter earnings season.